Spots Global Cancer Trial Database for recurrent childhood central nervous system embryonal tumor

Every month we try and update this database with for recurrent childhood central nervous system embryonal tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment	NCT00929903	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Metastatic Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi...	pazopanib hydro... pharmacological...	2 Years - 25 Years	National Cancer Institute (NCI)
Sunitinib in Treating Young Patients With Refractory Solid Tumors	NCT00387920	Central Nervous... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Recurrent Child... Unspecified Chi...	sunitinib malat... pharmacological... dynamic contras... laboratory biom...	2 Years - 21 Years	National Cancer Institute (NCI)
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors	NCT01158300	Brain and Centr...	VEGF inhibitor ...	3 Years - 21 Years	Pediatric Brain Tumor Consortium
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors	NCT00047320	Brain Tumor Central Nervous... Childhood Germ ...	carboplatin etoposide ifosfamide thiotepa adjuvant therap... conventional su... neoadjuvant the... peripheral bloo... radiation thera...	3 Years - 24 Years	Children's Oncology Group
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment	NCT00929903	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Metastatic Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi...	pazopanib hydro... pharmacological...	2 Years - 25 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors	NCT00281944	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Recurrent Child... Recurrent Child... Unspecified Chi...	oxaliplatin fluorouracil leucovorin calc... pharmacological... positron emissi... computed tomogr...	- 21 Years	National Cancer Institute (NCI)
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors	NCT00238173	Bone Marrow Sup... Brain and Centr... Drug/Agent Toxi... Long-term Effec...	filgrastim acetylcysteine carboplatin cyclophosphamid... etoposide phosp... mannitol sodium thiosulf...	1 Year - 18 Years	OHSU Knight Cancer Institute
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors	NCT00281944	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Recurrent Child... Recurrent Child... Unspecified Chi...	oxaliplatin fluorouracil leucovorin calc... pharmacological... positron emissi... computed tomogr...	- 21 Years	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: